• 1. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Imidazoles Substituted imidazoles

Comprehensive Overview of 1-(Azetidin-3-yl)-1H-imidazole (CAS No. 278789-06-3): Properties, Applications, and Research Insights

1-(Azetidin-3-yl)-1H-imidazole (CAS No. 278789-06-3) is a heterocyclic compound featuring an azetidine ring fused with an imidazole moiety. This unique structure has garnered significant attention in pharmaceutical and chemical research due to its potential as a versatile building block for drug discovery. The compound's molecular formula and structural characteristics make it particularly valuable in the design of bioactive molecules targeting various therapeutic areas.

In recent years, the demand for small-molecule scaffolds like 1-(Azetidin-3-yl)-1H-imidazole has surged, driven by the growing focus on fragment-based drug design and medicinal chemistry optimization. Researchers frequently search for "azetidine derivatives in drug discovery" or "imidazole-containing bioactive compounds," reflecting the compound's relevance in modern pharmaceutical R&D. Its balanced lipophilicity and hydrogen-bonding capacity contribute to favorable drug-like properties, making it a promising candidate for further exploration.

The synthetic routes for 1-(Azetidin-3-yl)-1H-imidazole typically involve multi-step organic transformations, often utilizing protecting group strategies to ensure regioselectivity. Current literature highlights its potential as a kinase inhibitor core structure, with particular interest in "modulators of protein-protein interactions" – a hot topic in targeted therapy development. The compound's three-dimensional geometry offers distinct advantages over flat aromatic systems in addressing challenging biological targets.

From a physicochemical perspective, 1-(Azetidin-3-yl)-1H-imidazole exhibits moderate water solubility and stability under physiological conditions, as evidenced by its performance in high-throughput screening assays. These characteristics align with current industry preferences for lead compounds with improved developability profiles. The scientific community continues to investigate its potential in addressing "undruggable targets" – a frequently searched term in biopharmaceutical research circles.

Recent patent analyses reveal growing intellectual property activity surrounding azetidine-imidazole hybrids, particularly in applications related to central nervous system disorders and inflammatory conditions. This trend corresponds with increasing online queries about "novel heterocyclic compounds for neurological applications." The compound's conformational rigidity and vectorial diversity make it particularly attractive for designing allosteric modulators – another area of intense research interest.

In computational chemistry studies, 1-(Azetidin-3-yl)-1H-imidazole has demonstrated favorable molecular docking characteristics against several therapeutic targets. These findings support its classification as a privileged structure in medicinal chemistry – a concept frequently explored in "scaffold hopping strategies" searches. The compound's pharmacophore features enable diverse interactions with biological macromolecules, explaining its utility across multiple drug discovery projects.

Quality control of 1-(Azetidin-3-yl)-1H-imidazole typically involves advanced analytical techniques such as HPLC purity analysis and mass spectrometry characterization. These methods ensure batch-to-batch consistency for research applications, addressing common concerns about "compound purity in biological assays" – a critical consideration for reproducible results. The compound's stability profile under various storage conditions has been systematically evaluated to support its use in long-term research programs.

Emerging applications of 1-(Azetidin-3-yl)-1H-imidazole extend beyond traditional pharmaceuticals, with preliminary studies suggesting potential in materials science and catalysis. This versatility aligns with current interdisciplinary trends in chemical research, often searched as "multifunctional heterocyclic compounds." The compound's electronic properties and coordination chemistry characteristics open possibilities for innovative applications in functional materials design.

From a regulatory standpoint, 1-(Azetidin-3-yl)-1H-imidazole is recognized as a research chemical with no significant restrictions for laboratory use. However, proper handling protocols should always be followed, consistent with general laboratory safety practices – an aspect frequently addressed in "chemical handling guidelines" searches. The compound's material safety data has been thoroughly documented to support responsible research applications.

Future research directions for 1-(Azetidin-3-yl)-1H-imidazole may explore its potential in bioconjugation chemistry and prodrug development, responding to growing interest in "targeted drug delivery systems." The compound's functional group compatibility and derivatization potential position it as a valuable tool for addressing contemporary challenges in precision medicine approaches. Ongoing structure-activity relationship studies continue to reveal new dimensions of its pharmacological potential.

• 153836-44-3(1-(azetidin-3-yl)imidazole;hydrochloride)
• 1211472-59-1(N-Ethyl-2-(1-imidazolyl)ethanamine)
• 924714-15-8(1-(1H-imidazol-1-yl)propan-2-amine)
• 790190-74-8(2-imidazol-1-ylmethyl-piperazine)
• 135207-17-9(1-Cyclopropyl-1H-imidazole)
• 900717-84-2(2-(1H-Imidazol-1-yl)propylamine hydrochloride)
• 1158449-43-4(2-Imidazol-1-yl-1-methyl-ethylamine Dihydrochloride)
• 106891-44-5((2-Imidazol-1-yl-ethyl)-methyl-amine Dihydrochloride)
• 4532-96-1(1-Isopropylimidazole)
• 64074-20-0(1-(Pyrrolidin-3-yl)-1H-imidazole)